Compare EYPT & FCF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EYPT | FCF |
|---|---|---|
| Founded | 1987 | 1934 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Major Banks |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | 2005 | N/A |
| Metric | EYPT | FCF |
|---|---|---|
| Price | $16.10 | $17.09 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $29.60 | $19.50 |
| AVG Volume (30 Days) | ★ 1.1M | 602.5K |
| Earning Date | 11-05-2025 | 01-27-2026 |
| Dividend Yield | N/A | ★ 3.15% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.39 |
| Revenue | $42,339,000.00 | ★ $468,728,000.00 |
| Revenue This Year | N/A | $17.40 |
| Revenue Next Year | N/A | $7.44 |
| P/E Ratio | ★ N/A | $12.35 |
| Revenue Growth | N/A | ★ 2.69 |
| 52 Week Low | $3.91 | $13.54 |
| 52 Week High | $19.11 | $18.60 |
| Indicator | EYPT | FCF |
|---|---|---|
| Relative Strength Index (RSI) | 60.28 | 66.01 |
| Support Level | $15.97 | $16.46 |
| Resistance Level | $19.11 | $16.92 |
| Average True Range (ATR) | 0.96 | 0.33 |
| MACD | 0.11 | 0.11 |
| Stochastic Oscillator | 46.36 | 86.57 |
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.
First Commonwealth Financial Corp functions in the financial services sector in the United States. Through its subsidiary, it offers a range of consumer and commercial banking services such as personal checking accounts, interest-earning checking accounts, savings accounts, insured money market accounts, investment certificates, fixed & variable rate certificates of deposit, and various kinds of loans. It also provides trust and wealth management services and offers insurance products. The company earns the majority of its revenue through net interest income.